Targeting lysosome/RPE heterogeneity in AMD pathobiology as a novel therapy

$584,501R01FY2024EYNIH

Johns Hopkins University, Baltimore MD

Investigators

Debasish Sinhacontact James T Handa

Linked publications, trials & patents

Paper 39574597 Paper 39412071 Paper 39062975 Paper 39034314 Paper 37848361 Paper 36428965 Paper 35921555 Paper 35835183 Paper 35473441 Paper 35468037 Paper 34769409

View original record on NIH RePORTER →